EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives

Vincenzo Di Lauro, Alessandro Rizzo, Margherita Tafuro, Emanuela Fina, Claudia Martinelli, Claudia Calderaio, Rossana Di Rienzo, Miriam Pirolo, Annarita Fanizzi, Raffaella Massafra, Michelino De Laurentiis

Cancer Treatment Reviews · 2025-11 · 140 · 103023

DOI: 10.1016/j.ctrv.2025.103023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-11. Verfasst von Vincenzo Di Lauro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy. Hauptthemen laut MEDLINE: Immunoconjugates, Antibodies, Monoclonal, Humanized, Breast Neoplasms, Topoisomerase I Inhibitors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 106 Literaturangaben. Gefördert von: Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesAntibodies, Monoclonal, HumanizedBreast NeoplasmsTopoisomerase I InhibitorsCamptothecinCell Adhesion MoleculesClinical Trials as TopicHumansFemaleDose-Response Relationship, DrugNeoadjuvant TherapyChemotherapy, AdjuvantProgression-Free SurvivalAntigens, Neoplasm

Stichwörter der Autor:innen

Antibody-Drug ConjugatesBreast CancerDeruxtecanPredictive biomarkersTROP2Triple-Negative Breast Cancer

Substanzen

CamptothecinImmunoconjugatesAntibodies, Monoclonal, HumanizedTACSTD2 protein, humanCell Adhesion MoleculesTopoisomerase I InhibitorsAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy.
  • S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. Electronic address: Rizzo.alessandro179@gmail.com.
  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy; Scuola Superiore Meridionale (SSM), Clinical and Translational Oncology, Naples, Italy; Division of Med…
  • Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Napoli, Italy; Scuola Superiore Meridionale (SSM), Clinical and Translational Oncology, Naples, Italy.
  • Scuola Superiore Meridionale (SSM), Clinical and Translational Oncology, Naples, Italy; Division of Medical Oncology, Department of Clinical Medicine, University of Naples Federico II, Naples, Italy.

Förderung

  • Fondazione Umberto Veronesi

Zitieren

APA

Di Lauro, V., Rizzo, A., Tafuro, M., Fina, E., Martinelli, C., Calderaio, C., Di Rienzo, R., Pirolo, M., Fanizzi, A., Massafra, R., & De Laurentiis, M. (2025). Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives. Cancer Treatment Reviews, 140, 103023. https://doi.org/10.1016/j.ctrv.2025.103023

Vancouver

Di Lauro V, Rizzo A, Tafuro M, Fina E, Martinelli C, Calderaio C, et al. Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives. Cancer Treatment Reviews. 2025;140:103023. doi:10.1016/j.ctrv.2025.103023

BibTeX
@article{DiLauro2025,
  author = {Di Lauro, Vincenzo and Rizzo, Alessandro and Tafuro, Margherita and Fina, Emanuela and Martinelli, Claudia and Calderaio, Claudia and Di Rienzo, Rossana and Pirolo, Miriam and Fanizzi, Annarita and Massafra, Raffaella and De Laurentiis, Michelino},
  title = {Datopotamab deruxtecan: rational strategies, novel advancements, challenges, and future perspectives},
  journal = {Cancer Treatment Reviews},
  year = {2025},
  volume = {140},
  pages = {103023},
  doi = {10.1016/j.ctrv.2025.103023}
}
Kostenlos starten →